Treg and T-effector cells in autoimmune CNS inflammation: A delicate balance, easily disturbed

European Journal of Immunology

Volumn 40, Issue 12, 2010, Pages 3321-3324

  Anderton, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Autoimmune disease; EAE; LFA 1; Multiple sclerosis; Treg

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; CD4+ T LYMPHOCYTE; DISEASE MODEL; EFFECTOR CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HOMEOSTASIS; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 78649541561     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041100     Document Type: Article

References (22)

1. O'Connor, R. A. and Anderton, S. M., Foxp3+regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 2008. 193: 1-11.
2. Anderton, S. M. and Liblau, R. S., Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 2008. 21: 248-254.
3. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T. et al., Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 2007. 13: 423-431.
4. Gültner, S., Kuhlmann, T., Hesse, A., Weber, J. P., Riemer, C., Baier, M., and Hutloff, A., Reduced Treg frequency in LFA-1 deficient mice allows enhanced T effector differentiation and pathology in EAE. Eur. J. Immunol. 2010. 40: 3403-3412.
5. Perez, O. D., Mitchell, D., Jager, G. C., South, S., Murriel, C., McBride, J., Herzenberg, L. A. et al. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat. Immunol. 2003. 4: 1083-1092.
6. Shimizu, Y., LFA-1: more than just T cell Velcro. Nat. Immunol. 2003. 4: 1052-1054.
7. Wang, Y., Shibuya, K., Yamashita, Y., Shirakawa, J., Shibata, K., Kai, H., Yokosuka, T. et al. LFA-1 decreases the antigen dose for T cell activation in vivo. Int. Immunol. 2008. 20: 1119-1127.
8. Laschinger, M., Vajkoczy, P. and Engelhardt, B., Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur. J. Immunol. 2002. 32: 3598-3606.
9. McGeachy, M. J., Stephens, L. A. and Anderton, S. M., Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+regulatory cells within the central nervous system. J. Immunol. 2005. 175: 3025-3032.
10. O'Connor, R. A., Malpass, K. H. and Anderton, S. M., The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+regulatory T cells. J. Immunol. 2007. 179: 958-966.
11. Villares, R., Cadenas, V., Lozano, M., Almonacid, L., Zaballos, A., Martinez, A. C. and Varona, R., CCR6 regulates EAE pathogenesis by controlling regulatory CD4+T-cell recruitment to target tissues. Eur. J. Immunol. 2009. 39: 1671-1681.
12. Onishi, Y., Fehervari, Z., Yamaguchi, T. and Sakaguchi, S., Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 2008. 105: 10113-10118.
13. Marski, M., Kandula, S., Turner, J. R. and Abraham, C., CD18 is required for optimal development and function of CD4+CD25+T regulatory cells. J. Immunol. 2005. 175: 7889-7897.
14. Hu, X., Wohler, J. E., Dugger, K. J. and Barnum, S. R., beta2-integrins in demyelinating disease: not adhering to the paradigm. J. Leukoc. Biol. 2010. 87: 397-403.
15. Dugger, K. J., Zinn, K. R., Weaver, C., Bullard, D. C. and Barnum, S. R., Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2009. 206: 22-27.
16. Wohler, J., Bullard, D., Schoeb, T. and Barnum, S., LFA-1 is critical for regulatory T cell homeostasis and function. Mol. Immunol. 2009. 46: 2424-2428.
17. Flugel, A., Willem, M., Berkowicz, T. and Wekerle, H., Gene transfer into CD4+T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat. Med. 1999. 5: 843-847.
18. Zhang, X., Koldzic, D. N., Izikson, L., Reddy, J., Nazareno, R. F., Sakaguchi, S., Kuchroo, V. K. and Weiner, H. L., IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+regulatory T cells. Int. Immunol. 2004. 16: 249-256.
19. Montero, E., Nussbaum, G., Kaye, J. F., Perez, R., Lage, A., Ben-Nun, A. and Cohen, I. R., Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+and CD8+T cells: analysis using depleting antibodies. J. Autoimmun. 2004. 23: 1-7.
20. Stephens, L. A., Gray, D. and Anderton, S. M., CD4+CD25+regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. USA 2005. 102: 17418-17423.
21. Picca, C. C., Oh, S., Panarey, L., Aitken, M., Basehoar, A. and Caton, A. J., Thymocyte deletion can bias Treg formation toward low-abundance self-peptide. Eur. J. Immunol. 2009. 39: 3301-3306.
22. Verhagen, J., Gabrysova, L., Minaee, S., Sabatos, C. A., Anderson, G., Sharpe, A. H. and Wraith, D. C., Enhanced selection of FoxP3+T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc. Natl. Acad. Sci. USA 2009. 106: 3306-3311.